Oct 29, 2024 · Anti–amyloid-beta MABs, however, are a new approach to treatment that targets underlying amyloid-beta pathology and facilitates the clearance of amyloid-beta aggregates by unbundling the amyloid ...

A) Smear slide showing amyloid (metachromatic, purple) around a capillary (toluidin blue stain), B) paraffin-embedded material: extensive amyloid deposition around capillaries in cortex (Aβ ...

Cerebral amyloid angiopathy (CAA) is a common but often asymptomatic disease, characterized by deposition of amyloid in cerebral blood vessels. We describe the successful treatment of CAA ...

Cite this: Steroid Responsive Encephalopathy in Cerebral Amyloid Angiopathy: A Case Report and Review of Evidence for Immunosuppressive Treatment - Medscape - Mar 01, 2010.

Background . Sporadic cerebral amyloid angiopathy (CAA) is a common but often asymptomatic neuropathological finding, characterized by the deposition of amyloid-β (Aβ) in small and medium-sized ...

Sep 12, 2023 · But let's get up to speed on cerebral amyloid angiopathy (CAA) first. CAA is characterized by the deposition of amyloid protein in the brain. While there are some genetic causes, they are quite ...

Oct 30, 2024 · A pretreatment MRI should be obtained within 1 year of initiating treatment and patients showing severe white-matter disease or evidence of significant cerebral amyloid angiopathy (eg, four or ...

Sep 13, 2023 · New research hints at the possibility that cerebral amyloid angiopathy (CAA), a cause of spontaneous brain hemorrhage, can be transmitted via blood transfusion, raising the risk for spontaneous ...

May 22, 2020 · "This significant difference was restricted to APOE e4 carriers" (P = .049), as well as those with cerebral amyloid angiopathy (P = .02) and/or vascular, ischemic, or hemorrhagic pathology (P ...

Aug 6, 2024 · Dr Bradford Dickerson shares his clinical experience in using amyloid plaque–lowering monoclonal antibodies in Alzheimer's disease. This site is intended for healthcare professionals .